Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Evaluation of the Role of Plerixafor in Peripheral Blood Progenitor Cell Mobilization and Collection in Autologous Donors with Multiple Myeloma and Non-Hodgkin Lymphoma

Isabelle Blais-Normandin, MD, Philippe Nadeau, PhD, Linda Vallée, Rémy Angers, BSc, Manon Lescault, Nathalie Laflamme, PhD, Narcisse Singbo, Vincent Laroche, MD

Blood (2019) 134 (Supplement_1): 5635.

https://doi.org/10.1182/blood-2019-122511

Published: 2019

Journal Articles

Chemosensitive Disease Better Predicts Outcome Than Age Following Autologous Heamatopoietic Stem Cell Transplantation in Elderly Patients with Multiple Myeloma

Christopher Lemieux, MD, Robert Delage, MD, Guy Cantin, MD, Frederic Barabe, MD, Vincent Laroche, MD, Rémy Angers, BSc, Genevieve Gallagher, MD

Blood (2017) 130 (Supplement 1): 5530.

https://doi.org/10.1182/blood.V130.Suppl_1.5530.5530

Published: 2017

Journal Articles

Description Of The Hematological Toxicity Of Different Regimens Using Bortezomib In Multiple Myeloma (CyborD, Vel-Dex and VMP)

Dominic Duquette, BPharm, MSc, Vincent Laroche, MD,FRCPC

Blood (2013) 122 (21): 5386.

https://doi.org/10.1182/blood.V122.21.5386.5386

Published: 2013

Journal Articles

Implementing Cybord As First-Line Therapy For Transplant-Eligible Multiple Myeloma Patients : A Single-Center Preliminary Comparaison

Dominic Duquette, BPharm, MSc, Vincent Laroche, MD, FRCPC

Blood (2013) 122 (21): 5403.

https://doi.org/10.1182/blood.V122.21.5403.5403

Published: 2013

Journal Articles

The Influence of Bleeding on Trigger Changes for Platelet Transfusion in Chemotherapy-Induced Thrombocytopenic Patients

Benjamin Rioux-Masse, MD, FRCPC, Vincent Laroche, MD, FRCPC, Robert J. Bowman, MD, Bruce R. Lindgren, MS, Claudia S. Cohn, MD, PhD, Shelley M. Pulkrabek, MT(ASCP), CCRC, Terri Carr, RN, BSN, Darin Sumstad, MT(ASCP), Jeffrey McCullough, MD

Blood (2011) 118 (21): 1260.

https://doi.org/10.1182/blood.V118.21.1260.1260

Published: 2011

NARROW

Evaluation of the Role of Plerixafor in Peripheral Blood Progenitor Cell Mobilization and Collection in Autologous Donors with Multiple Myeloma and Non-Hodgkin Lymphoma

Chemosensitive Disease Better Predicts Outcome Than Age Following Autologous Heamatopoietic Stem Cell Transplantation in Elderly Patients with Multiple Myeloma

Description Of The Hematological Toxicity Of Different Regimens Using Bortezomib In Multiple Myeloma (CyborD, Vel-Dex and VMP)

Implementing Cybord As First-Line Therapy For Transplant-Eligible Multiple Myeloma Patients : A Single-Center Preliminary Comparaison

The Influence of Bleeding on Trigger Changes for Platelet Transfusion in Chemotherapy-Induced Thrombocytopenic Patients

Email alerts

ASH Publications

American Society of Hematology

Evaluation of the Role of Plerixafor in Peripheral Blood Progenitor Cell Mobilization and Collection in Autologous Donors with Multiple Myeloma and Non-Hodgkin Lymphoma

Chemosensitive Disease Better Predicts Outcome Than Age Following Autologous Heamatopoietic Stem Cell Transplantation in Elderly Patients with Multiple Myeloma

Description Of The Hematological Toxicity Of Different Regimens Using Bortezomib In Multiple Myeloma (CyborD, Vel-Dex and VMP)

Implementing Cybord As First-Line Therapy For Transplant-Eligible Multiple Myeloma Patients : A Single-Center Preliminary Comparaison

The Influence of Bleeding on Trigger Changes for Platelet Transfusion in Chemotherapy-Induced Thrombocytopenic Patients

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only